Schizophrenia research and treatment

Schizophrenia is a severe psychiatric disorder marked by psychosis, disorganized thinking, and persistent deficits in memory, attention, and social cognition, affecting roughly one percent of the global population across cultures and socioeconomic groups. Researchers investigate its origins through genetic association studies and neurodevelopmental models, which together suggest that the illness emerges from a complex interplay of inherited risk and early disruptions to brain maturation, often signaled years before psychosis by subtle prodromal symptoms. Antipsychotic drugs remain the cornerstone of treatment by targeting dopamine dysregulation, but they address positive symptoms far better than the neurocognitive and social-cognitive impairments that most determine long-term functioning, and their frequent association with metabolic syndrome raises serious concerns about physical health outcomes. A central open question is whether combining pharmacological treatment with cognitive therapies and early intervention during the prodromal period can meaningfully alter the illness trajectory before the brain changes underlying schizophrenia become entrenched.

Works

140,651

Total citations

3,344,798

Keywords

Antipsychotic DrugsNeurocognitive DeficitsGenetic Association StudiesMetabolic SyndromeNeurodevelopmental ModelCognitive Therapy